Brussels, 10/05/2012 (Agence Europe) - In a ruling in Case C-100/IIP on 10 May 2012, the European Court of Justice rejected the appeal by Helena Rubinstein SNC and l'Oréal SA and confirmed the cancellation firstly by the European Harmonisation of Trademarks Office (OHIM), followed by the European General Court's cancellation of their trademarks Botolist and Botocyl respectively because they indirectly benefit too much from the fame of the Botox trademark. The Court of Justice says that the European General Court had not made any mistake in law in its confirmation in a ruling on 16 December 2010 on Cases T345/08 and T-357/08 of OHIM's decisions of May and June 2008 following a complaint by Allergan Inc, which owns the Botox trademark. The Court of Justice ruled that the European General Court had correctly assessed the existence of wide public renown for the Botox trademark among the general public and beauticians in the United Kingdom, as suggested in evidence submitted by Allergan and could therefore legitimately decide that there was a connection between the two trademarks in question and Helena Rubinstein and L'Oréal's desire to take advantage of the fame of Botox by giving their products a similar name. (FG/transl.fl)